through proprietary devices that enable direct antibiotic treatment of infected joints
Periprosthetic Joint Infection (PJI) is devastating to patient health, frustrating to surgeons, and costly to the healthcare system.
PJI presents as Acute, Chronic or Hematogenous. This is a growing problem. Without infection control improvement, the estimated WW treatment cost in 2020 is $1.6B.
ForCast Orthopedics is improving orthopedic surgical outcomes through proprietary total joint arthroplasty devices that enable direct antibiotic treatment of joints for remediation of infection whenever it occurs